Challenges and shifting treatment strategies in the surgical treatment of locally advanced rectal cancer
Abstract The current standard treatment for locally advanced rectal cancer (LARC) in Korea and Western countries is a multimodal approach incorporating preoperative long‐course chemoradiotherapy (LCRT) followed by total mesorectal excision (TME) and adjuvant chemotherapy. This approach has significa...
Main Authors: | Ho Seung Kim, Nam Kyu Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-07-01
|
Series: | Annals of Gastroenterological Surgery |
Subjects: | |
Online Access: | https://doi.org/10.1002/ags3.12349 |
Similar Items
-
Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Ming‐Yii Huang, et al.
Published: (2020-03-01) -
Early recurrence after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: Characteristics and risk factors
by: Han-Gil Kim, et al.
Published: (2021-01-01) -
Advances in the treatment of locally advanced rectal cancer
by: Fadwa Ali, et al.
Published: (2021-01-01) -
The high pCR rate of sandwich neoadjuvant treatment in locally advanced rectal cancer may translate into a better long-term survival benefit: 5-year outcome of a Phase II clinical trial
by: Hu YH, et al.
Published: (2018-10-01) -
Data on patterns of initial recurrence after curative surgery for rectal cancer with neoadjuvant therapy
by: Zhifang Zheng, et al.
Published: (2020-10-01)